Page last updated: 2024-10-27

berotek and Myocarditis

berotek has been researched along with Myocarditis in 1 studies

Fenoterol: A synthetic adrenergic beta-2 agonist that is used as a bronchodilator and tocolytic.
fenoterol : A member of the class resorcinols that is 5-(1-hydroxyethyl)benzene-1,3-diol in which one of the methyl hydrogens is replaced by a 1-(4-hydroxyphenyl)propan-2-amino group. A beta2-adrenergic agonist, it is used (as the hydrobromide salt) as a bronchodilator in the management of reversible airway obstruction.

Myocarditis: Inflammatory processes of the muscular walls of the heart (MYOCARDIUM) which result in injury to the cardiac muscle cells (MYOCYTES, CARDIAC). Manifestations range from subclinical to sudden death (DEATH, SUDDEN). Myocarditis in association with cardiac dysfunction is classified as inflammatory CARDIOMYOPATHY usually caused by INFECTION, autoimmune diseases, or responses to toxic substances. Myocarditis is also a common cause of DILATED CARDIOMYOPATHY and other cardiomyopathies.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bender, HG1
Goeckenjan, G1
Meger, C1
Müntefering, H1

Other Studies

1 other study available for berotek and Myocarditis

ArticleYear
[The possible maternal risk of tocolytic therapy with fenoterol (partusisten) (author's transl)].
    Geburtshilfe und Frauenheilkunde, 1977, Volume: 37, Issue:8

    Topics: Adult; Autopsy; Ethanolamines; Female; Fenoterol; Humans; Myocarditis; Obstetric Labor, Premature; P

1977